An antibody in single-chain fragment variable (scFv) format that binds to the powerful opioid carfentanil was shown to reverse signs of carfentanil overdose in preclinical tests conducted by scientists at Scripps Research.
Carfentanil is a variant of the synthetic opioid fentanyl, and about 100 times as potent as its chemical cousin.